viernes, 6 de octubre de 2017

National Breast Cancer Awareness Month (see related guidelines) 2 | National Guideline Clearinghouse

Search | National Guideline Clearinghouse

ngc



  • GUIDELINE SUMMARY
  •  
  • NGC:009457
  •  
  • 1997 MAY (REVISED 2013 MAR 1)

Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update.

  • GUIDELINE SUMMARY
  •  
  • NGC:009391
  •  
  • 2012 AUG

Sentinel lymph node biopsy and axillary node dissection in early stage breast cancer.

  • GUIDELINE SUMMARY
  •  
  • NGC:010700
  •  
  • 2014 SEP 30

Optimal systemic therapy for early female breast cancer.

  • GUIDELINE SUMMARY
  •  
  • NGC:009378
  •  
  • 2012 JUL

Staging investigations for asymptomatic and newly diagnosed breast cancer.

  • GUIDELINE SUMMARY
  •  
  • NGC:011064
  •  
  • 2016 JUN 8

Clinical utility of multigene profiling assays in invasive early-stage breast cancer.

  • GUIDELINE SUMMARY
  •  
  • NGC:010541
  •  
  • 2013 AUG

Intraoperative tests (RD-100i OSNA system and Metasin test) for detecting sentinel lymph node metastases in breast cancer.

  • GUIDELINE SUMMARY
  •  
  • NGC:009074
  •  
  • 2012 APR

Eribulin for the treatment of locally advanced or metastatic breast cancer.

  • GUIDELINE SUMMARY
  •  
  • NGC:011200
  •  
  • 2017 MAR-APR

Accelerated partial breast irradiation: executive summary for the update of an ASTRO evidence-based consensus statement.

  • GUIDELINE SUMMARY
  •  
  • NGC:010045
  •  
  • 2007 MAY (REVISED 2013 SEP)

Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society.

  • GUIDELINE SUMMARY
  •  
  • NGC:011028
  •  
  • 2016

ACR Appropriateness Criteria® breast cancer screening.

  • GUIDELINE SUMMARY
  •  
  • NGC:009678
  •  
  • 1999 (REVISED 2012)

ACR Appropriateness Criteria® single brain metastasis.

  • GUIDELINE SUMMARY
  •  
  • NGC:008960
  •  
  • 1994 JAN (REVISED 2012 JAN)

Diagnosis of breast disease.

  • GUIDELINE SUMMARY
  •  
  • NGC:009376
  •  
  • 2012 OCT

Denosumab for the prevention of skeletal-related events in adults with bone metastases from solid tumours.

  • GUIDELINE SUMMARY
  •  
  • NGC:009658
  •  
  • 1996 SEP (REVISED 2012)

ACR Appropriateness Criteria® palpable breast masses.

  • GUIDELINE SUMMARY
  •  
  • NGC:011169
  •  
  • 2017 FEB

Breast reconstruction following prophylactic or therapeutic mastectomy for breast cancer.

No hay comentarios:

Publicar un comentario